Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission, we hope you enjoy your experience

ETGLX Eventide Gilead N

  • Fund
  • ETGLX
  • Price as of: Jul 19, 2019
  • $42.14 - $0.28 - 0.66%
  • Category
  • Mid Cap Growth Equities

ETGLX - Profile

Vitals

  • YTD Return 33.1%
  • 3 Yr Annualized Return 19.7%
  • 5 Yr Annualized Return 12.1%
  • Net Assets $2.65 B
  • Holdings in Top 10 33.0%

52 WEEK LOW AND HIGH

$42.14
$29.36
$42.49

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.39%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 24.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

STANDARD (TAXABLE)

$1,000

IRA

$1,000

Investment Themes

CATEGORY

Mid Cap Growth Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Mid-Cap Growth

Distributions

  • YTD Total Return 33.9%
  • 3 Yr Annualized Total Return 20.0%
  • 5 Yr Annualized Total Return 12.5%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.16%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name Eventide Gilead Fund
  • Fund Family Name Eventide Funds
  • Inception Date Jul 08, 2008
  • Shares Outstanding N/A
  • Share Class N
  • Currency USD
  • Domiciled Country United States
  • Manager Finny Kuruvilla

ETGLX - Performance

Return Ranking - Trailing

Period ETGLX Return Category Return Low Category Return High Rank in Category (%)
YTD 33.1% -47.7% 49.8% 10.50%
1 Yr 8.0% -47.7% 20.6% 7.06%
3 Yr 19.7%* -23.8% 24.5% 3.09%
5 Yr 12.1%* -30.2% 15.3% 2.95%
10 Yr 15.9%* -11.8% 17.4% 0.85%

* Annualized


Return Ranking - Calendar

Period ETGLX Return Category Return Low Category Return High Rank in Category (%)
2018 -7.5% -52.1% 9.2% 14.72%
2017 32.9% -38.9% 36.0% 1.91%
2016 0.9% -61.7% 27.9% 54.58%
2015 -3.3% -82.5% 12.2% 24.56%
2014 17.7% -23.5% 17.9% 0.40%

Total Return Ranking - Trailing

Period ETGLX Return Category Return Low Category Return High Rank in Category (%)
YTD 33.9% -47.7% 49.8% 9.73%
1 Yr 8.7% -47.7% 29.8% 22.90%
3 Yr 20.0%* -22.2% 28.3% 4.84%
5 Yr 12.5%* -25.3% 17.4% 11.61%
10 Yr 16.2%* -6.4% 18.9% 7.37%

* Annualized


Total Return Ranking - Calendar

Period ETGLX Return Category Return Low Category Return High Rank in Category (%)
2018 -7.5% -51.7% 12.2% 33.65%
2017 32.9% -7.0% 56.2% 5.16%
2016 0.9% -61.7% 27.9% 80.12%
2015 -2.1% -54.0% 12.2% 51.46%
2014 17.9% -23.5% 18.1% 0.40%

NAV & Total Return History

ETGLX - Holdings

Concentration Analysis

ETGLX Category Low Category High ETGLX % Rank
Net Assets 2.65 B 1.44 M 33.8 B 29.01%
Number of Holdings 64 13 2232 71.37%
Net Assets in Top 10 785 M 616 K 7.12 B 21.76%
Weighting of Top 10 32.98% 6.7% 148.7% 21.76%

Top 10 Holdings

  1. Ascendis Pharma A/S ADR 5.56%

  2. Twilio Inc A 4.49%

  3. The Trade Desk Inc A 4.00%

  4. Wayfair Inc Class A 3.21%

  5. Sage Therapeutics Inc 3.21%

  6. Lowe's Companies Inc 2.60%

  7. Zogenix Inc 2.59%

  8. Roper Technologies Inc 2.54%

  9. Sarepta Therapeutics Inc 2.53%

  10. Waste Connections Inc 2.24%


Asset Allocation

Weighting Return Low Return High ETGLX % Rank
Stocks
83.63% 20.28% 127.86% 96.37%
Cash
15.17% -48.52% 36.01% 4.77%
Other
1.20% -7.94% 70.89% 4.58%
Preferred Stocks
0.00% 0.00% 3.25% 35.11%
Convertible Bonds
0.00% 0.00% 8.82% 33.78%
Bonds
0.00% -0.48% 43.05% 35.69%

Stock Sector Breakdown

Weighting Return Low Return High ETGLX % Rank
Technology
28.87% 0.00% 69.27% 39.12%
Healthcare
23.85% 0.00% 62.34% 3.82%
Consumer Cyclical
10.98% 0.00% 48.02% 81.68%
Industrials
10.93% 0.00% 38.67% 84.35%
Utilities
2.94% 0.00% 11.12% 8.02%
Real Estate
2.64% 0.00% 48.22% 54.20%
Basic Materials
2.41% 0.00% 13.78% 50.76%
Consumer Defense
0.63% 0.00% 17.24% 86.64%
Financial Services
0.00% 0.00% 40.09% 99.62%
Energy
0.00% 0.00% 14.07% 84.16%
Communication Services
0.00% 0.00% 11.66% 65.08%

Stock Geographic Breakdown

Weighting Return Low Return High ETGLX % Rank
US
75.89% 7.34% 123.93% 94.47%
Non US
7.74% 0.00% 70.47% 19.85%

ETGLX - Expenses

Operational Fees

ETGLX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.39% 0.07% 6.14% 34.61%
Management Fee 1.00% 0.06% 1.50% 92.75%
12b-1 Fee 0.20% 0.00% 1.00% 26.58%
Administrative Fee 0.10% 0.01% 0.72% 44.79%

Sales Fees

ETGLX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 0.00% 5.75% N/A
Deferred Load N/A 1.00% 5.50% N/A

Trading Fees

ETGLX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 0.05% 2.00% N/A

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

ETGLX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 24.00% 1.85% 495.00% 18.93%

ETGLX - Distributions

Dividend Yield Analysis

ETGLX Category Low Category High ETGLX % Rank
Dividend Yield 0.00% 0.00% 0.05% 41.79%

Dividend Distribution Analysis

ETGLX Category Low Category High Category Mode
Dividend Distribution Frequency Annually Annually Quarterly Annually

Dividend Payout History


Net Income Ratio Analysis

ETGLX Category Low Category High ETGLX % Rank
Net Income Ratio -0.16% -2.55% 4.79% 34.61%

Capital Gain Distribution Analysis

ETGLX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually Annually

ETGLX - Managers

Finny Kuruvilla

Manager

Start Date

Tenure

Tenure Rank

Jul 08, 2008

10.98

11.0%

Finny Kuruvilla, M.D., Ph.D., has been primarily responsible for the day-to-day management of the Gilead Fund and Healthcare & Life Sciences Fund since inception. Dr. Kuruvilla has been the Managing Partner of the Adviser since its inception in 2008. Dr. Kuruvilla possesses a diverse background in quantitative methods, with applications focused on innovations in science, engineering, and medicine. He holds an MD from Harvard Medical School, a PhD in Chemistry and Chemical Biology from Harvard University, a master’s degree in Electrical Engineering and Computer Science from MIT, and a bachelor’s degree from Caltech in Chemistry. From 2005-2008, Dr. Kuruvilla was a clinical fellow at the Brigham and Women's Hospital and a postdoctoral scientist at MIT. As an avid proponent of values-based investing, Dr. Kuruvilla has established rigorous standards in seeking out the most ethical companies at the outset of the stock selection process. In addition to his role with the Adviser, Dr. Kuruvilla is a founder, financial sponsor, and Board Director of Sattler College, a four-year college in Boston, Massachusetts, opened in 2018. Dr. Kuruvilla also contributes to the college in a limited faculty role. From 2008-2016, Dr. Kuruvilla provided research services as an employee of Clarus Ventures, a healthcare and life sciences venture capital firm. From 2006-2008, Dr. Kuruvilla was a research fellow at the Broad Institute of Harvard and MIT.


Tenure Analysis

Category Low

0.0

Category High

33.38

Category Average

8.62

Category Mode

8.84